Similar articles for PMID: 16882999

Year	Number of Results
1993	2
1995	1
1996	1
1997	1
1998	2
2001	6
2002	3
2003	2
2004	3
2005	5
2006	15
2007	16
2008	8
2009	6
2010	1
2011	8
2012	2
2013	1
2014	3
2015	4
2016	1
2017	2
2018	4
2019	2
2020	2
2024	0

1

Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.

Zalutsky MR. Zalutsky MR. J Nucl Med. 2006 Aug;47(8):1238-40. J Nucl Med. 2006. PMID: 16882999 Free article. No abstract available.

2

The promise of targeted {alpha}-particle therapy.

Mulford DA, Scheinberg DA, Jurcic JG. Mulford DA, et al. J Nucl Med. 2005 Jan;46 Suppl 1:199S-204S. J Nucl Med. 2005. PMID: 15653670 Free article. Review.

3

Radioimmunotherapy with alpha-particle emitting radionuclides.

Zalutsky MR, Pozzi OR. Zalutsky MR, et al. Q J Nucl Med Mol Imaging. 2004 Dec;48(4):289-96. Q J Nucl Med Mol Imaging. 2004. PMID: 15640792 Free article. Review.

4

Potential and pitfalls of therapy with alpha-particles.

Welch MJ. Welch MJ. J Nucl Med. 2005 Aug;46(8):1254-5. J Nucl Med. 2005. PMID: 16085579 Free article. No abstract available.

5

Can α-radioimmunotherapy increase efficacy for the systemic control of cancer?

Allen BJ. Allen BJ. Immunotherapy. 2011 Apr;3(4):455-8. doi: 10.2217/imt.11.13. Immunotherapy. 2011. PMID: 21463184 Free article. No abstract available.

6

Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.

Knogler K, Grünberg J, Zimmermann K, Cohrs S, Honer M, Ametamey S, Altevogt P, Fogel M, Schubiger PA, Novak-Hofer I. Knogler K, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):603-11. doi: 10.1158/1078-0432.CCR-06-1486. Clin Cancer Res. 2007. PMID: 17255283

7

[Alpha-radioimmunotherapy: a review of recent developments].

Supiot S, Thillays F, Rio E, Mahé MA, Barbet FJ, Kraeber-Bodéré F, Chérel M. Supiot S, et al. Cancer Radiother. 2007 Sep;11(5):252-9. doi: 10.1016/j.canrad.2007.05.001. Epub 2007 Jun 28. Cancer Radiother. 2007. PMID: 17604673 Review. French.

8

Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.

Pfost B, Seidl C, Autenrieth M, Saur D, Bruchertseifer F, Morgenstern A, Schwaiger M, Senekowitsch-Schmidtke R. Pfost B, et al. J Nucl Med. 2009 Oct;50(10):1700-8. doi: 10.2967/jnumed.109.065961. J Nucl Med. 2009. PMID: 19793735 Free article.

9

Targeted alpha therapy of prostate cancer.

Allen BJ, Li Y, Rizvi SM, Russell PJ. Allen BJ, et al. Methods Mol Med. 2003;81:333-57. doi: 10.1385/1-59259-372-0:333. Methods Mol Med. 2003. PMID: 12725130 No abstract available.

10

Tumor therapy with targeted atomic nanogenerators.

McDevitt MR, Ma D, Lai LT, Simon J, Borchardt P, Frank RK, Wu K, Pellegrini V, Curcio MJ, Miederer M, Bander NH, Scheinberg DA. McDevitt MR, et al. Science. 2001 Nov 16;294(5546):1537-40. doi: 10.1126/science.1064126. Science. 2001. PMID: 11711678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year